Smith, S. A., Ogawa, S. A., Chau, L., Whelan, K. A., Hamilton, K. E., Chen, J., . . . Wu, G. D. (2021). Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitines. J Clin Invest.
Citación estilo ChicagoSmith, Sarah A., et al. "Mitochondrial Dysfunction in Inflammatory Bowel Disease Alters Intestinal Epithelial Metabolism of Hepatic Acylcarnitines." J Clin Invest 2021.
Cita MLASmith, Sarah A., et al. "Mitochondrial Dysfunction in Inflammatory Bowel Disease Alters Intestinal Epithelial Metabolism of Hepatic Acylcarnitines." J Clin Invest 2021.
Precaución: Estas citas no son 100% exactas.